Brief: Pfizer Says Litfulo Safety Profile In NSV Consistent With Alopecia Areata

Pfizer

02/10/2026 18:24

Oct 2 (Reuters) - Pfizer Inc. PFE.N:
PFIZER’S LITFULO SIGNIFICANTLY IMPROVED FACIAL AND TOTAL BODY REPIGMENTATION IN PATIENTS WITH NONSEGMENTAL VITILIGO~
PFIZER - TO SUBMIT LITFULO PHASE 3 DATA TO FDA AND EMA
PFIZER - LITFULO SAFETY PROFILE IN NSV CONSISTENT WITH ALOPECIA AREATA; NO NEW SAFETY SIGNALS
Source text: ID:nBw2gHCtza
Further company coverage: PFE.N

 ((Reuters.Briefs@thomsonreuters.com;))